Form EFFECT ENANTA PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 20, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- Consolidated Lithium Metals Announces Relocation of Headquarters to Québec, Name Change to Nordique Critical Metals Inc., and TSXV Symbol Change to NQC
- HMPI Focuses on Opportunities in Georgia and Expands Overseas Operational Support Services for International Businesses
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
